Global Bridge Pharmaceutical Inc
Global Bridge Pharmaceutical is a licensed pharmaceutical consulting and distribution corporation located in Charlotte, NC.
Our goal is to provide consultancy services to enhance pharmaceutical practice and the effective use of medicines.
We also procure and distribute USFDA approved prescription and over the counter drugs to pharmacies, hospitals and other licensed healthcare facilities.
We are SAM registered as a minority company to do business with local, state and federal government through set asides or direct bids.
Our export services help US based pharmaceutical companies to expand to new markets through Global Access Program (GAP), Managed Access Program (MAP), Named Patient Program (NPP) as well as Export Management services and Contract Manufacturing.
WELCOME TO GB PHARMACEUTICAL
We have built long lasting relationships based on trust.
While working on a postgraduate research project on Pharmacovigilance through a grant from The University of Ferrara Italy and utilizing resources available at Queens University in New York, our founder Eric became increasingly aware that besides the safety concern of the drugs marketed in most developing countries and even some developed nations, access and cost were major issues to address.
MANAGED ACCESS PROGRAMS
DIASPORA MEDICINE INITIATIVE
To collaborate with health-care professionals and stakeholders both here in the United States and around the world, building meaningful relationships and providing solutions to their pharmaceutical and therapeutic needs.
To provide access to the same quality and safe medicines available in the United States to patients, pharmacies, hospitals, and wholesalers around the world.
At Global Bridge, we understand the importance of having access to up-to-date guidelines on drug therapy and medical information in your practice or hospital system.
Utilizing data and resources available in the United States, we can collaborate with the pharmacy and therapeutics committee (PTC) of your hospital or organization to develop a drug formulary based on the most recent guidelines.
Latest from blog
Growing resistance to HIV drugs in Africa is threatening the significant progress made in the global fight against the virus. In an effort to reinforce
Up to 650 000 deaths annually are associated with respiratory diseases from seasonal influenza, according to new estimates by the United States Centers for Disease